Reference
Kataoka T, et al. [Comparison of Pegfilgrastim and Filgrastim for the Primary Prophylactic Effect for Preventing Febrile Neutropenia in Patients Undergoing Rituximab with Dose-adjusted EPOCH Chemotherapy]. [Japanese]. Yakugaku Zasshi 139: 629-633, No. 4, Jan 2019. Available from: URL: http://doi.org/10.1248/yakushi.18-00101 - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1755, 35 (2019). https://doi.org/10.1007/s40278-019-62589-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62589-5